Pathology and Laboratory Medicine

Episodes 1-15 of 59

• 

  RestartResume

  Incorporation of guideline recommendations into the frontline care of a patient with mCRPC who is naïve to both docetaxel and novel hormone therapy

  MinuteCE®

  Incorporation of guideline recommendations into the frontline care of a patient with mCRPC who is naïve to both docetaxel and novel hormone therapy

  • 

    

    Wenxin Xu, MD

    Peer

  • 

    

    Sandy Srinivas, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Guideline-recommended first-line treatment with immunotherapy and targeted therapy combinations in renal cell carcinoma

  MinuteCE®

  Guideline-recommended first-line treatment with immunotherapy and targeted therapy combinations in renal cell carcinoma

  • 

    

    Wenxin Xu, MD

    Peer

  • 

    

    Sandy Srinivas, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer

  MinuteCE®

  Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer

  • 

    

    Ignacio Duran, MD

    Peer

  • 

    

    Sandy Srinivas, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Guideline recommendations for first-line treatment intensification with PARP inhibitor combinations in patients with metastatic castration-resistant prostate cancer

  MinuteCE®

  Guideline recommendations for first-line treatment intensification with PARP inhibitor combinations in patients with metastatic castration-resistant prostate cancer

  • 

    

    Wenxin Xu, MD

    Peer

  • 

    

    Sandy Srinivas, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Emerging targeted therapy combination strategies in genitourinary malignancies

  MinuteCE®

  Emerging targeted therapy combination strategies in genitourinary malignancies

  • 

    

    Ignacio Duran, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Emerging immunotherapy combination strategies in genitourinary malignancies

  MinuteCE®

  Emerging immunotherapy combination strategies in genitourinary malignancies

  • 

    

    Sandy Srinivas, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Guideline-recommended second-line treatment following an immune checkpoint inhibitor in renal cell carcinoma

  MinuteCE®

  Guideline-recommended second-line treatment following an immune checkpoint inhibitor in renal cell carcinoma

  • 

    

    Ignacio Duran, MD

    Peer

  • 

    

    Wenxin Xu, MD

    Peer

  1.25 program credits

• 

  MinuteCE®

  Innovations in Oncology Learning Center From Guidelines to Practice: Genitourinary Cancers

  • 

    

    Ignacio Duran, MD

    Peer

  • 

    

    Wenxin Xu, MD

    Peer

  • 

    

    Sandy Srinivas, MD

    Peer

  1.25 credits 10 episodes

• 

  RestartResume

  Incorporation of guideline-concordant care for first-line treatment of a patient with metastatic urothelial carcinoma

  MinuteCE®

  Incorporation of guideline-concordant care for first-line treatment of a patient with metastatic urothelial carcinoma

  • 

    

    Ignacio Duran, MD

    Peer

  • 

    

    Sandy Srinivas, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Insights from global key opinion leaders on optimizing patient care in genitourinary malignancies

  MinuteCE®

  Insights from global key opinion leaders on optimizing patient care in genitourinary malignancies

  • 

    

    Ignacio Duran, MD

    Peer

  • 

    

    Wenxin Xu, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer

  MinuteCE®

  Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer

  • 

    

    Ignacio Duran, MD

    Peer

  • 

    

    Wenxin Xu, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference

  CME/CE Broadcast Replay

  Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference

  • 

    

    John H. Stone, MD, MPH

    Peer

  • 

    

    Yoh Zen, MD, PhD, FRCPath

    Peer

  • 

    

    Avinash Kambadakone-Ramesh, MD, DNB, FRCR

    Peer

  • 

    

    J. Matthias Löhr, MD

    Peer

  1.00 credits

• 

  RestartResume

  The Evolving Role of MET TKIs in NSCLC

  CME/CE

  The Evolving Role of MET TKIs in NSCLC

  • 

    

    Gilberto de Lima Lopes, Jr, MD, MBA, FASCO

    Peer

  • 

    

    Jyoti Patel, MD

    Peer

  0.75 credits

• 

  RestartResume

  Endpoints in Adjuvant Breast Cancer Trials: Implications for Clinical Practice

  MinuteCE®

  Endpoints in Adjuvant Breast Cancer Trials: Implications for Clinical Practice

  • 

    

    Hope S. Rugo, MD, FASCO

    Peer

  • 

    

    Nadia Harbeck, MD, PhD

    Peer

  1.25 program credits

• 

  RestartResume

  Case: A Patient With HR+/HER2- EBC at High-Risk for Recurrence

  MinuteCE®

  Case: A Patient With HR+/HER2- EBC at High-Risk for Recurrence

  • 

    

    Hope S. Rugo, MD, FASCO

    Peer

  • 

    

    Nadia Harbeck, MD, PhD

    Peer

  1.25 program credits

• 1
• 2
• 3
• 4
• Next